Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nanoparticles Help Disrupt Tumor Blood Supply, Destroy Tumors

Abstract:
In recent years, cancer researchers have been developing agents that destroy the blood vessels surrounding tumors with the goal of starving tumors to death. Some of these agents, such as tumor necrosis factor-alpha (TNF-α) have shown promising results, but often their toxicity has proven too great to be clinically useful. Using gold nanoparticles as a delivery vehicle for TNF-α has reduced this toxicity and the resulting construct has already completed a phase I clinical trial in humans.

Nanoparticles Help Disrupt Tumor Blood Supply, Destroy Tumors

Bethesda, MD | Posted on July 15th, 2013

Now, a team at the University of Minnesota headed by John Bischof, has shown that they can use this gold nanoparticle-TNF-α system to enhance the effects of either thermal therapy or cryosurgery. Moreover, the researchers demonstrated that they can use standard magnetic resonance imaging technology to visualize tumor destruction. Dr. Bischof and his colleagues reported their findings in the journal Molecular Pharmaceutics.

Experiments in a mouse model of human prostate cancer showed that the gold nanoparticle-TNF-α system disrupted blood flow into tumors within 90 minutes of injection, an effect that lasted up to six hours. Using a technique known as dynamic contrast-enhanced MRI, Dr. Bischof's team was able to clearly image the changes in blood flow into and around the tumor following nanoparticle treatment. The researchers note that in human patients, a simple five-minute MRI scan would be sufficient to detect a meaningful change in tumor blood vessel function.

Once the tumor blood vessels had been "preconditioned," Dr. Bischof and his collaborators treated the animals with either thermal therapy or cryosurgery, both of which produced marked reductions in tumors. They noted that none of the animals treated with thermal therapy died, an important finding given that an equivalent dose of TNF-α with no gold nanoparticle attached followed by thermal therapy was found to be lethal in a large percentage of animals. The researchers also showed that nanoparticle-delivered TNF-α did not trigger inflammatory reactions associated with activated neutrophils, something that does occur when tumors are treated with native TNF-α.

####

About The National Cancer Institute (NCI)
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

Copyright © The National Cancer Institute (NCI)

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

View abstract - "Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy."

Related News Press

News and information

ANU invention to inspire new night-vision specs December 7th, 2016

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Journal Nanotechnology Progress International (JONPI), newest edition out December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

Govt.-Legislation/Regulation/Funding/Policy

Physicists decipher electronic properties of materials in work that may change transistors December 6th, 2016

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Discoveries

ANU invention to inspire new night-vision specs December 7th, 2016

Leti IEDM 2016 Paper Clarifies Correlation between Endurance, Window Margin and Retention in RRAM for First Time: Paper Presented at IEDM 2016 Offers Ways to Reconcile High-cycling Requirements and Instability at High Temperatures in Resistive RAM December 6th, 2016

Tokyo Institute of Technology research: 3D solutions to energy savings in silicon power transistors December 6th, 2016

Physicists decipher electronic properties of materials in work that may change transistors December 6th, 2016

Announcements

ANU invention to inspire new night-vision specs December 7th, 2016

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Journal Nanotechnology Progress International (JONPI), newest edition out December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

ANU invention to inspire new night-vision specs December 7th, 2016

Journal Nanotechnology Progress International (JONPI), newest edition out December 7th, 2016

Tokyo Institute of Technology research: 3D solutions to energy savings in silicon power transistors December 6th, 2016

Physicists decipher electronic properties of materials in work that may change transistors December 6th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project